Theralase Technologies Inc. V.TLT

Advise from MSAB!!

[Infinity]

Finally, TLT has opted to present trial results in a form that is acceptable to FDA the main recipient to evaluate.   I am not complaining, better late than never!!.  Thanks to MSAB.    
I still have one question.  How did the evaluable patients at 450 Days jump to 37 Patients.  
Ref. "  What am I missing?  

• Five patients have been enrolled and provided the primary Study Treatment but have not been evaluated at their 90 day assessment; therefore, 52 patients are considered Evaluable Patients at 90 days, with 37 patients considered Evaluable Patients at 450 days.

[Eoganacht]

The evaluable patients at 450 days is now 37 because this number now includes all of the NR patients (the red dots) that are on the ASCO swimmer's plot (from the Nov. 29 results), plus the 4 non-NR patients at 360 days, plus the 3 non-NR patients at 270 days. If you add them all up that's 12 at 450 + 18 NR + 4 non-NR at 360 + 3 non-NR at 270 = 37 patients If you look at the ASCO Swimmer&

[Infinity]

Thank you Eoga,  That would imply that we could have many more patients who would have reached 450 Days post first treatment by end of this year. Seems like we are tracking well towards BTD and AA.